Improving hearing with AI noise reduction in hearing aids
Evaluation of Artificial Intelligence Based Noise Reduction in Phonak Hearing Aid on Patients With Hearing Impairment and Cochlear Implants
This study is testing a new AI noise reduction feature in Phonak hearing aids to see if it helps people with hearing loss hear and understand speech better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 110 Years |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT06743295 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of an artificial intelligence-based noise reduction system integrated into Phonak hearing aids. It will assess whether this technology can provide measurable improvements in hearing and speech perception for individuals with hearing impairment. Participants will include those who do not currently use hearing aids, those who do, and cochlear implant patients with a single-sided implant. The intervention involves the DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip designed to enhance auditory experiences.
Who should consider this trial
Good fit: Ideal candidates include individuals with hearing impairment who are either not using hearing aids or currently using them, as well as cochlear implant patients with a single-sided implant.
Not a fit: Patients with normal hearing or those who do not have hearing impairment may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this could significantly enhance the hearing experience for patients with hearing loss.
How similar studies have performed: Other studies have shown promise in using AI for hearing enhancement, suggesting a potential for success with this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with hearing impairment not using hearing aids * Individuals with hearing impairment currently using hearing aids * Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Aniket Saoji, PhD — Mayo Clinic
- Study coordinator: Clinical Research Study Coordinator
- Email: tombers.nicole@mayo.edu
- Phone: 507-293-2445
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.